Basel Institute for Immunology

Last updated

The Basel Institute for Immunology (BII) was founded in 1969 as a basic research institute in immunology located at 487 Grenzacherstrasse, Basel, Switzerland on the Rhine River down the street from the main Hoffmann-La Roche campus near the Swiss-German border. [1] The institute opened its doors in 1971.

Contents

Description

It was a unique concept in the history of mechanisms for funding basic science and the relationship between basic science and industry. Through the influence of Paul Sacher, [2] Swiss conductor and patron of the arts and sciences, drug company Hoffmann-LaRoche committed unrestricted support of $24 million per year and freedom of design of the institute to its founding director Niels K. Jerne. Jerne retired in 1980 and was succeeded by Fritz Melchers, [3] who generally maintained Jerne's themes and vision. [4]

Culture and achievements

Establishment of the BII coincided with a convergence of a critical mass of young and energetic scientists from around the world in Basel to staff three startup research ventures to exploit the newly breaking technologies related to molecular biology, gene cloning and development of mouse models. In addition to BII, these were the Friedrich Miescher Institute (FMI) [5] sponsored by Ciba-Geigy (now Novartis) and the Biozentrum [6] sponsored by the University of Basel. In the 1970s it was estimated that 17 different languages were spoken at the institute united by English, the common language of science. Social gatherings between the international staff of the three institutes and heated discussions concerning lifestyles, the arts and in particular science in the pubs of Basel were common in the period.

The BII was known as a training ground for independent thinking and career development rather than a place to be for an entire career. While maintaining a relatively constant core of 50 scientists over its 30-year history, the average age of which was at any one time 35 years, the BII gave rise to over 500 scientists who worked and trained there who with their scientific progeny represent the core of the field of immunology worldwide. [4] [7] [8] [9] Institute scientists were awarded 27 prestigious international awards in immunology [7] that include three Nobel Prizes, Georges J.F. Köhler, Niels K. Jerne, and Susumu Tonegawa.

Dissolution

In 2000, the BII was dissolved by Hoffmann-La Roche to be succeeded at the Hoffmann-LaRoche campus by a more traditional mission- and profit-oriented research and development (R&D) division of the company, the Roche Center for Medical Genomics. [10]

Related Research Articles

<span class="mw-page-title-main">Paul Sacher</span>

Paul Sacher was a Swiss conductor, patron and billionaire businessman. At the time of his death Sacher was majority shareholder of pharmaceutical company Hoffmann-La Roche and was considered the third richest person in the world with an estimated net worth of US$13 billion.

<span class="mw-page-title-main">University of Basel</span> Public university in Basel, Switzerland

The University of Basel is a public research university in Basel, Switzerland. Founded on 4 April 1460, it is Switzerland's oldest university and among the world's oldest surviving universities. The university is traditionally counted among the leading institutions of higher learning in the country.

<span class="mw-page-title-main">Roche</span> Swiss multinational healthcare company

F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.

<span class="mw-page-title-main">Polly Matzinger</span> French-born American immunologist

Polly Celine Eveline Matzinger is a French-born immunologist who proposed the danger model theory of how the immune system works.

The Marcel Benoist Prize, offered by the Marcel Benoist Foundation, is a monetary prize that has been offered annually since 1920 to a scientist of Swiss nationality or residency who has made the most useful scientific discovery. Emphasis is placed on those discoveries affecting human life. Since 1997, candidates in the humanities have also been eligible for the prize.

<span class="mw-page-title-main">Niels Kaj Jerne</span> Danish immunologist (1911–1994)

Niels Kaj Jerne, FRS was a Danish immunologist. He shared the Nobel Prize in Physiology or Medicine in 1984 with Georges J. F. Köhler and César Milstein "for theories concerning the specificity in development and control of the immune system and the discovery of the principle for production of monoclonal antibodies".

<span class="mw-page-title-main">César Milstein</span> Argentine biochemist (1927–2002)

César Milstein, CH, FRS was an Argentine biochemist in the field of antibody research. Milstein shared the Nobel Prize in Physiology or Medicine in 1984 with Niels Kaj Jerne and Georges J. F. Köhler for developing the hybridoma technique for the production of monoclonal antibodies.

<span class="mw-page-title-main">Georges J. F. Köhler</span> German biologist (1946–1995)

Georges Jean Franz Köhler was a German biologist.

<span class="mw-page-title-main">Fritz Hoffmann-La Roche</span> Swiss businessman

Fritz Hoffmann-La Roche, later Fritz Hoffmann-von der Mühll, was a Swiss businessman who founded the pharmaceutical company F. Hoffmann-LaRoche & Co.

<span class="mw-page-title-main">Science and technology in Switzerland</span> Overview of science and technology in Switzerland

Science and technology in Switzerland play an important role in the Swiss economy, which has very few natural resources that are available in the country. The Swiss National Science Foundation, mandated by the Federal government, is the most important institute for promoting scientific research.

John Wilcox Stocker AO FTSE FRACP is an Australian immunologist and the former Chairman of the Board of the Commonwealth Scientific and Industrial Research Organisation (CSIRO), the national government body for scientific research in Australia. Stocker is a former Chief Scientist of Australia.

Geoffrey W. Hoffmann, is an Australian-Canadian theoretical biologist. Hoffmann was a faculty member in the Department of Physics at the University of British Columbia and the founder of Network Immunology Inc. in Vancouver, Canada. He is best known for symmetric immune network theory.

<span class="mw-page-title-main">Friedrich Miescher Institute for Biomedical Research</span> Facility in Basel, Switzerland

The Friedrich Miescher Institute for Biomedical Research (FMI) is a biomedical research institute founded in 1970. Based in Basel, Switzerland, the FMI is affiliated with the University of Basel and the Novartis Institutes for BioMedical Research (NIBR). It is named after Friedrich Miescher. As of 2021, the FMI has around 340 collaborators, of which 20 are research group leaders, over 80 are postdoctoral collaborators and over 80 are postgraduate students participating in the FMI International PhD Program. The FMI is directed by Dirk Schübeler.

<span class="mw-page-title-main">Luc Hoffmann</span> Swiss ornithologist, conservationist and philanthropist

Hans Lukas "Luc" Hoffmann was a Swiss ornithologist, conservationist, and philanthropist. He co-founded the World Wildlife Fund (WWF), helped establish the Ramsar Convention for the protection of wetlands, and set up the Tour du Valat research centre in the Camargue area of France.

<span class="mw-page-title-main">Szent-Györgyi Prize for Progress in Cancer Research</span>

The Szent-Györgyi Prize for Progress in Cancer Research, established by National Foundation for Cancer Research (NFCR) and named in honor of Albert Szent-Györgyi, Nobel laureate and co-founder of NFCR, has been awarded annually since 2006 to outstanding researchers whose scientific achievements have expanded the understanding of cancer and whose vision has moved cancer research in new directions. The Szent-Györgyi Prize honors researchers whose discoveries have made possible new approaches to preventing, diagnosing and/or treating cancer. The Prize recipient is honored at a formal dinner and award ceremony and receives a $25,000 cash prize. In addition, the recipient leads the next "Szent-Györgyi Prize Committee" as honorary chairman.

<span class="mw-page-title-main">Biozentrum University of Basel</span> Division of the University of Basel

Research at the Biozentrum of the University of Basel is dedicated to the central question of how molecules and cells create life − from atom to organism, and from the physics of life to the dynamics of multicellular systems. Accordingly, the scientists at the Biozentrum are active in a wide range of research fields. These disciplines are not strictly separated from each other, but often overlap, thus leading to new questions and collaborations.

Susan M. Gasser is a Swiss molecular biologist. From 2004 to 2019 she was the director of the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland, where she also led a research group from 2004 until 2021. She was in parallel professor of molecular biology at the University of Basel until April 2021. Since January 2021, Susan Gasser is director of the ISREC Foundation, which supports translational cancer research. She is also professor invité at the University of Lausanne in the department of fundamental microbiology. She is an expert in quantitative biology and studies epigenetic inheritance and genome stability. Recipient of multiple swiss and European awards, she was named member of the US Academy of Sciences in 2022.

<span class="mw-page-title-main">Jnanendra Das Gupta</span>

Jnanendra Chandra Das Gupta was an Indian-born chemist who developed a thermosetting plastic called Indolack while working in the Swedish company Perstorp. This led to the development of the first plastic called "isolit" used in Sweden.

Emanuel Hoffmann was a Swiss jurist and art collector. He was the son of Fritz Hoffmann-La Roche, a founder of the pharmaceutical company Hoffmann-La Roche, and his first wife.

<span class="mw-page-title-main">Maja Sacher</span> Swiss art collector (1896-1989)

Maja Sacher was a Swiss art collector and philanthropist.

References

  1. Lefkovitz, Ivan (2017). History of the Basel Institute of Immunology (1st ed.). Karger. doi:10.1159/isbn.978-3-318-05935-9. ISBN   978-3-318-05934-2.
  2. "Paul Sacher Foundation Website". Archived from the original on November 24, 2006.
  3. "CV Fritz Melchers".
  4. 1 2 "Closing of Basel institute scatters immunologists. Science 293, 238-239, 2001".
  5. "FMI Home page". fmi.ch.
  6. "Home - Biozentrum". www.biozentrum.unibas.ch.
  7. 1 2 [30 Years Basel Institute for Immunology, (History, Milestones, Press Articles, Annual Reports, Publications, List of Institute Members), Souvenir CD/DVD 2001]
  8. [Publications & Annual Reports 1972-1999]
  9. Dembic, Zlatko (2011). "My Basel Institute for Immunology, My BII, My Bias". Scandinavian Journal of Immunology. 73 (6): 505–507. doi: 10.1111/j.1365-3083.2011.02552.x . PMID   21521248. S2CID   6773084.
  10. Abbott, Alison (June 1, 2000). "Roche brings down curtain on Swiss immunology lab". Nature. 405 (6787): 605–605. doi:10.1038/35015238 via www.nature.com.

47°33′46″N7°37′35″E / 47.5628°N 7.6263°E / 47.5628; 7.6263